Full text
PDFPage 118
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chester A. H., Martin G. R., Bodelsson M., Arneklo-Nobin B., Tadjkarimi S., Tornebrandt K., Yacoub M. H. 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res. 1990 Nov;24(11):932–937. doi: 10.1093/cvr/24.11.932. [DOI] [PubMed] [Google Scholar]
- Connor H. E., Feniuk W., Humphrey P. P. 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation. Eur J Pharmacol. 1989 Feb 14;161(1):91–94. doi: 10.1016/0014-2999(89)90184-2. [DOI] [PubMed] [Google Scholar]
- Ginsburg R., Bristow M. R., Davis K., Dibiase A., Billingham M. E. Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries. Circulation. 1984 Feb;69(2):430–440. doi: 10.1161/01.cir.69.2.430. [DOI] [PubMed] [Google Scholar]
- Kalsner S. Coronary artery reactivity in human vessels: some questions and some answers. Fed Proc. 1985 Feb;44(2):321–325. [PubMed] [Google Scholar]
- Willett F., Curzen N., Adams J., Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan. BMJ. 1992 May 30;304(6839):1415–1415. doi: 10.1136/bmj.304.6839.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]